Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions have come together to form an Integrated CMC Partnership—a unique collaboration offering innovator biopharma companies end-to-end Chemistry, Manufacturing & Controls (CMC) services.

By combining complementary strengths — Sai in API development, Agility in  formulation sciences, and Centrix in drug product development and clinical manufacturing—we help innovators move efficiently from preclinical studies to first-inhuman (FIH) trials and beyond.

Key benefits include:

• Broad expertise across the CMC value chain, supported by state-of-the-art labs and manufacturing facilities.

• End-to-end coverage: from synthetic route scouting to drug substance manufacturing, and from pre-formulation to clinical trial materials.

• Cross-functional optimization that reduces duplication, risks, costs, and timelines.

• Flexibility to proactively address emerging technical risks.

• Seamless knowledge flow and sample transfer between technical teams.

• Single point of contact from Day One for alignment and accountability

Very few seats left, book now to save a spot.